case_images: PMC8573811_01
case_images: Initial (A) and repeat (B) chest radiograph.
case_images: AJTCCM-27-3-116-fig1.jpg
case_images: PMC8573811_01_AJTCCM-27-3-116-fig1.jpg
case_images: F1
case_images: In addition, the left lower zone revealed an ill-defined area of ground glass opacification (Fig. 1A). A repeat chest radiograph in July 2019 revealed that the lesions had increased in size (Fig. 1B).
case_images: Computed tomography scan of the chest.
case_images: AJTCCM-27-3-116-fig2.jpg
case_images: PMC8573811_01_AJTCCM-27-3-116-fig2.jpg
case_images: F2
case_images: This was associated with pulmonary nodules and left pleural thickening (Figs 2A and B).
case_images: A photomicrograph of an H & E stain lung showing necrotising granulomatous inflammation and fibrous thickening of the pleura (A), 20x
  magnification. A photomicrograph of a section stained with Alcian Blue and PAS (ABPAS) showing fungal elements with morphological features
  of Cryptococcus (B).
case_images: AJTCCM-27-3-116-fig3.jpg
case_images: PMC8573811_01_AJTCCM-27-3-116-fig3.jpg
case_images: F3
case_images: Owing to the peripheral nature of these lesions, she underwent a CT-guided transthoracic lung biopsy, which revealed fibrous connective tissue with evidence of chronic necrotising granulomatous inflammation and fungal organisms with the morphological features of Cryptococcus (Figs 3A and B).
case_images: Repeat chest radiograph (A) and computed tomography images 6 months after initiation of therapy (B).
case_images: AJTCCM-27-3-116-fig4.jpg
case_images: PMC8573811_01_AJTCCM-27-3-116-fig4.jpg
case_images: F4
case_images: Follow-up chest radiography revealed partial resolution of the lesions noted previously (Fig. 4A).  Fluconazole 200 mg twice daily for 3 months and then 200 mg daily thereafter was continued. Subsequent repeat CT imaging done 6 months after initiation of therapy revealed resolution of lung nodules and masses, with some residual fibro-cavitary lung changes remaining in areas previously involved by mass formation (Fig. 4B).